1 August 2024
Volex plc
("Volex" or "the Company")
Results of Annual General Meeting
Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is pleased to announce the results of its AGM, held earlier today, at which all resolutions were duly passed on a poll.
The total number of votes received on each resolution put to the AGM is as follows:
| | Resolution | % in Favour | Votes For | Votes Against | Total Votes Cast | % of issued share capital voted | Votes Withheld* |
| 1. | To receive the audited accounts of the Company for the financial year ended 31 March 2024 | 99.99% | 92,770,635 | 3,567 | 92,774,202 | 51.08% | 11,209,194 |
| 2. | To approve the Remuneration Committee Report | 97.64% | 101,512,601 | 2,455,444 | 103,968,045 | 57.25% | 15,351 |
| 3. | To declare a final dividend of 2.8 pence per ordinary share for the financial year ended 31 March 2024 | 99.99% | 103,979,545 | 78 | 103,979,623 | 57.25% | 3,773 |
| 4. | To elect John Wilson as a Director | 99.69% | 103,658,732 | 318,306 | 103,977,038 | 57.25% | 6,358 |
| 5. | To re-elect Jon Boaden as a Director | 99.69% | 103,650,976 | 326,062 | 103,977,038 | 57.25% | 6,358 |
| 6. | To re-elect Amelia Murillo as a Director | 99.75% | 103,717,556 | 258,040 | 103,975,596 | 57.25% | 7,800 |
| 7. | To re-elect Sir Peter Westmacott as a Director | 96.79% | 100,636,425 | 3,338,236 | 103,974,661 | 57.25% | 8,735 |
| 8. | To re-appoint PricewaterhouseCoopers LLP as auditors of the Company | 98.99% | 102,922,096 | 1,047,996 | 103,970,092 | 57.25% | 13,304 |
| 9. | To authorise the Directors to determine the remuneration of the auditors | 99.45% | 103,394,990 | 576,017 | 103,971,007 | 57.25% | 12,389 |
| 10. | To authorise the Directors to allot shares in the Company pursuant to section 551 of the Companies Act 2006 ("2006 Act") | 99.60% | 103,562,525 | 413,551 | 103,976,076 | 57.25% | 7,320 |
| 11. | To authorise the disapplication of statutory pre-emption rights under section 570 of the 2006 Act | 98.61% | 102,530,071 | 1,446,205 | 103,976,276 | 57.25% | 7,120 |
| 12. | To authorise the further disapplication of statutory pre-emption rights under section 570 of the 2006 Act in connection with an acquisition or specified capital investment | 97.48% | 101,352,269 | 2,624,007 | 103,976,276 | 57.25% | 7,120 |
| 13. | To authorise the Company to make purchases of its own shares in accordance with section 701 of the 2006 Act | 99.97% | 103,684,365 | 29,934 | 103,714,299 | 57.11% | 269,097 |
Notes
*A vote withheld is not treated as a vote in law and is not counted in the calculation of the proportion of the votes cast for or against a resolution.
Resolutions 1 to 10 were ordinary resolutions, requiring a simple majority of votes cast to pass, while resolutions 11 to 13 were special resolutions, requiring at least 75% support to pass.
The total number of Volex shares in issue at 6.00 p.m. on 30 July 2024, being those eligible to be voted on at the AGM, was 181,617,533.
The full text of each of the resolutions is set out in the Notice of AGM, which is available on the Volex website (www.volex.com) on the "Shareholder Information" page in the Investor Relations section.
For further information please contact:
Volex plc +44 (0)7971 156 431
Nat Rothschild, Executive Chairman investor.relations@volex.com
Jon Boaden, Chief Financial Officer
Chris Bedford, Group General Counsel and Company Secretary
Peel Hunt LLP - Nominated Adviser & Joint Broker +44 20 7418 8900
Ed Allsopp
Dom Convey
Ben Harrington
HSBC Bank plc - Joint Broker +44 20 7991 8888
Simon Alexander
Joe Weaving
Stephanie Cornish
Sodali & Co - Media Enquiries +44 20 7250 1446
James White
Nicholas Johnson
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.